Is Tyvaso (treprostinil) covered by Medicare Part D?
174 of 5,052 Medicare Part D plan offerings (3.4%) list Tyvaso on their 2026 formulary, most often on tier 5; 89.5% of the formularies that cover it require prior authorization. Part D spending on it was $737 million in 2024 for at least 4,385 people: what plans and patients paid at the pharmacy, before manufacturer rebates (CMS Part D Spending by Drug).
- Plans that cover it
- 3.4%
- 174 of 5,052 offerings; the median drug: 76%
- Usual tier
- Tier 5
- from tier 1 to tier 5
- Prior authorization
- 89.5%
- of formularies that cover it; the median drug: 1%
- Quantity limits
- 21.1%
- of formularies that cover it; the median drug: 30%
Source: CMS Part D formulary file, 2026 second quarter: the formularies in use in 2026. A plan's 2027 formulary can differ; check your own plan's coverage in Medicare Plan Finder.
What does it cost under Part D in 2027?
- Your yearly cap in 2027
- Out-of-pocket spending on covered Part D drugs stops at $2,400 in 2027 ($2,100 in 2026); after that, you pay nothing for covered drugs for the rest of the year.
- The deductible
- A plan's drug deductible is at most $700 in 2027 ($615 in 2026); many plans charge less or none.
Source: CMS, Announcement of calendar year 2027 Part D parameters; Medicare.gov, “How much does Medicare drug coverage cost?” (read Oct. 7, 2026).
How much does Medicare spend on it?
Part D spending by year
4,385 people filled it under Part D in 2024, in 30,717 claims. The amounts are what plans and patients paid at the pharmacy, before manufacturer rebates.
Source: CMS Medicare Part D Spending by Drug, 2020 to 2024 (published June 2026). Row used: Tyvaso Dpi (Treprostinil), Tyvaso Refill Kit (Treprostinil/Neb Accessories), Tyvaso Starter Kit (Treprostinil/Nebulizer/Accesor).
Which forms and strengths are counted?
- treprostinil 0.016 mg inhalation powder
- treprostinil 0.032 mg inhalation powder
- treprostinil 0.048 mg inhalation powder
- treprostinil 0.064 mg inhalation powder
- treprostinil 0.08 mg inhalation powder
- pack of 112 × treprostinil 0.016 mg inhalation powder and 112 × treprostinil 0.032 mg inhalation powder and 28 × treprostinil 0.048 mg inhalation powder
- pack of 112 × treprostinil 0.032 mg inhalation powder and 112 × treprostinil 0.064 mg inhalation powder
- pack of 112 × treprostinil 0.048 mg inhalation powder and 112 × treprostinil 0.064 mg inhalation powder
Which other versions are listed?
The same ingredients under other names, each with its own coverage and spending.
- Orenitram (treprostinil)37% of plan offerings
- Yutrepia (treprostinil)15% of plan offerings
What else should you check?
- Stand-alone drug plans for 2027Premiums and deductibles
- Drugs Medicare spends the most onThe 2024 spending list
- 2027 costs and limitsDeductibles and out-of-pocket limits
Data, not medical advice. Coverage is the share of plan formularies listing the drug; your plan's formulary, tier and pharmacy decide what you pay.